PLSH
Panacea Life Sciences Holdings, Inc.Company with tickers: PLSH
Market Cap
$794,040
Shares Outstanding
17,645,352
CIK
1552189
CUSIP
69810P109
Website
Visit website
Investor Relations
Investor relations
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,056,447 | USD | 2024-03-31 | 10-Q | 2024-05-06 |
| Interest & Dividend Income | — | ||||
| Net Interest Income | — | ||||
| Noninterest Income | — | ||||
| Total Net Revenue | — | ||||
| Premiums Earned (Net) | — | ||||
| Cost of Revenue | $390,282 | USD | 2024-03-31 | 10-Q | 2024-05-06 |
| Gross Profit | $666,165 | USD | 2024-03-31 | 10-Q | 2024-05-06 |
| Operating Expenses | $1,723,513 | USD | 2024-03-31 | 10-Q | 2024-05-06 |
| Research & Development | — | ||||
| Operating Income | $-1,057,348 | USD | 2024-03-31 | 10-Q | 2024-05-06 |
| Net Income | $-1,446,074 | USD | 2024-03-31 | 10-Q | 2024-05-06 |
| EPS (Basic) | $-0.09 | USD/shares | 2024-03-31 | 10-Q | 2024-05-06 |
| EPS (Diluted) | $-0.09 | USD/shares | 2024-03-31 | 10-Q | 2024-05-06 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Geography (USD)
| Component | 2022-12-31 |
|---|---|
| Largo Florida | $2,900,000 |